Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JTECTSE:3446 -0.21%56 Market Cap is 円8,520 Mil as of Jul. 30, 2026. GuruFocus rates TSE:3446 with a GF Score™ of 56/100 and a GF Value™ of 円2,140.06 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 862 Medical Devices & Instruments companies, JTEC ranks worse than 60.56% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). JTEC's share price for the quarter that ended in Mar. 2026 was 円1835. JTEC's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 6 Mil. Therefore, JTEC's market cap for the quarter that ended in Mar. 2026 was 円10,836 Mil.
JTEC's quarterly market cap
declined
from Sep. 2025 (円7,021 Mil) to Dec. 2025 (円7,009 Mil) but then
increased
from Dec. 2025 (円7,009 Mil) to Mar. 2026 (円10,836 Mil).
JTEC's annual market cap
declined
from Jun. 2023 (円13,682 Mil) to Jun. 2024 (円9,471 Mil) and
declined
from Jun. 2024 (円9,471 Mil) to Jun. 2025 (円7,368 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. JTEC's Enterprise Value for Today is 円8,505 Mil.
JTEC (TSE:3446) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
JTEC Market Cap Related Terms
JTEC Market Cap Historical Data
* Premium members only.
The historical data trend for JTEC's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3446 vs ISRG, BDX, MDLN: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, JTEC's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JTEC Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JTEC's Market Cap distribution charts can be found below:
* The bar in red indicates where JTEC's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
JTEC's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JTEC (TSE:3446) has a Market Cap of 円8,520 Mil as of Jul. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on JTEC and its competitors. According to the industry distribution chart, JTEC ranks #522 out of 862 companies in the Medical Devices & Instruments industry, placing it in the top 60.6%.
Is JTEC's Market Cap too high?
JTEC's current Market Cap is 円8,520 Mil. Based on the distribution chart, JTEC ranks #522 out of 862 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, JTEC has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JTEC's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JTEC ranks #522 out of 862 companies for Market Cap. This places JTEC in the lower half of its industry. The industry median Market Cap is 109.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 109.80, based on 862 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on JTEC and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 109.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JTEC's current Market Cap is 円8,520 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JTEC stock overvalued right now?
Based on GuruFocus' analysis, JTEC (TSE:3446) is currently considered Significantly Undervalued. The stock's GF Value™ is 円2,140.06, compared to a current price of 円1,440.00 — trading 32.7% below its estimated fair value. The current Market Cap is 円8,520 Mil. JTEC's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For JTEC (TSE:3446), the current Market Cap is 円8,520 Mil as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JTEC (TSE:3446) Overvalued in 2026?
Based on GuruFocus' analysis, JTEC stock appears to be undervalued.
The current stock price of 円1,440.00 is trading 32.7% below its estimated GF Value™ of 円2,140.06.
GuruFocus considers JTEC to be Significantly Undervalued.
Key valuation signals for TSE:3446:
Market Cap: 円8,520 Mil
GF Value™: 円2,140.06 vs. price of 円1,440.00 (32.7% below fair value)
No single metric tells the full story. See the TSE:3446 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JTEC Corp is engaged in developing, designing, manufacturing and sales of Automated Cell Culture System; X-ray Mirrors for Synchrotron Facilities; and Automated System in various fields. Its products in optical business include Kirkpatrick-Baez (KB) mirror, Advanced KB mirror (1D Wolter mirror), Montel mirror, Ellipsoidal mirror, 2D Walter mirror, Deformable mirror, Multi-channel mirror, X-ray focusing alignment system (JM1000 / 2000 series), Additional mirror shaping improvement, and Mirror coating. Its products in life science include CELLFLOAT products and Automated Cell Culture Systems.
56GF Score
Get the complete analysis for TSE:3446
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3446 has been successfully added to your 
